Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions.
Dipen J. Parekh(University of Miami), Joseph A. Smith(King's College London), Travis Clark(Vanderbilt University), Michael S. Cookson(University of Oklahoma Health Sciences Center), Sam S. Chang(Memorial Sloan Kettering Cancer Center), Jeffrey O’Connor(Vanderbilt University)
Cited by 36
Related Papers
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
|New England Journal of Medicine|2003|2k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome
|The Journal of Urology|1997|555